Heghine Khachatryan: A Valuable Educational Resource on Inhibitor Development
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared European Association for Haemophilia and Allied Disorders (EAHAD)’s post on LinkedIn, adding:
“An outstanding educational initiative.
As gene therapy continues to transform haemophilia care, a deeper understanding of inhibitor development remains fundamental to ensuring both efficacy and long-term safety.
Thank you for this valuable educational resource.”
European Association for Haemophilia and Allied Disorders (EAHAD) shared a post on LinkedIn:
“Missed our latest Gene Therapy online session or want to rewatch it?
The full replay of ‘Inhibitor Development in Gene Therapy for Haemophilia’ is now available on the EAHAD Academy.
And stay tuned for our next Gene Therapy webinar!”
Other posts featuring Heghine Khachatryan on Hemostasis Today.
-
Aug 21, 2026, 15:17Leveraging Data to Drive Sustainable Care for Haemophilia and Haemoglobinopathies – NNHF
-
Aug 21, 2026, 15:04Sex Differences in Platelet Function in Type 2 Diabetes – Seminars in Thrombosis and Hemostasis
-
Aug 21, 2026, 15:04Parth Parmar: RBC Morphology – A Practical Guide to Blood Smear Interpretation
-
Aug 21, 2026, 14:32Kenneth Nollet: Building the Future of Transfusion Laboratory Science
-
Aug 21, 2026, 14:14Tareq Abadl: A Positive Antibody Screen is Not The Diagnosis
-
Aug 21, 2026, 14:08Katrina Snow։ Transfusion Trends and Quality Improvement in Sickle Cell Disease
-
Aug 21, 2026, 14:00Rucha Patil: The Power of Point-of-Care Testing in Hemostasis
-
Aug 21, 2026, 13:56Sarah Kowalski։ Supporting the Next Generation of Transfusion Laboratory Scientists
-
Aug 21, 2026, 13:51Join EHC 2026 Annual Conference